TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis
Open Access
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Allergology International
- Vol. 67 (4) , 487-495
Abstract
No abstract availableKeywords
Funding Information
- Kansai Medical University Hospital
- Novartis Pharma Research (2017)
This publication has 32 references indexed in Scilit:
- T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosisEuropean Respiratory Journal, 2011
- A Novel Mechanism for CCR4 in the Regulation of Macrophage Activation in Bleomycin-Induced Pulmonary FibrosisThe American Journal of Pathology, 2008
- Systemic evaluation of a potential cutaneous sarcoidosis patientClinics in Dermatology, 2007
- Elevated levels of interferon γ‐inducible protein‐10 and epithelial neutrophil‐activating peptide‐78 in patients with pulmonary sarcoidosisRespirology, 2006
- Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseasesJournal of Dermatological Science, 2006
- Expression of CXCR6 and its ligand CXCL16 in the lung in health and diseaseClinical & Experimental Allergy, 2005
- Serum thymus and activation‐regulated chemokine, macrophage‐derived chemokine and eotaxin as markers of severity of atopic dermatitisAllergy, 2005
- Increased interleukin-13 expression in patients with sarcoidosisThorax, 2003
- Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus VectorJournal of Biological Chemistry, 1996
- Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis.Thorax, 1979